GFAP and Brain atrophy: As a confirmation, glial fibrillary acidic protein (GFAP), a marker of astrogliosis, has been measured in several genetic mutations, including C9ORF72, GRN, and MAPT, and showed to be increased only in symptomatic GRN mutation carriers, correlating also with lower cognitive scores and brain atrophy [120].